BiotechTube
Home/Medivir/Jens Lindberg
JL

Jens Lindberg

Chief Executive Officer (CEO)

Medivir

Therapeutic Areas

OncologyLiver Cancer

Medivir Pipeline

DrugIndicationPhase
Fostroxacitabine bralpamide (MIV-818)Hepatocellular Carcinoma (HCC)Phase 2a
Protease Inhibitor Discovery ProgramsOncology (Undisclosed)Discovery
Nucleoside/Nucleotide Discovery ProgramsOncology (Undisclosed)Discovery

Leadership Team at Medivir

FÖ
Fredrik Öberg
Chief Medical Officer (CMO)
PS
Pernilla Sandwall
Chief Financial Officer & Head of Operations (CFO)
UH
Uli Hacksell
Chairman of the Board
View full Medivir profile